DUBLIN--(BUSINESS WIRE)--The "Neurostimulation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
The global neurostimulation devices market reached a value of US$ 5.5 Billion in 2019. Looking forward, the market is expected to reach a value of US$ 9.6 Billion by 2025, registering a CAGR of 9.5% during 2020-2025.
The rising instances of neurological and lifestyle-related disorders, along with the rapidly growing geriatric population across the globe, are among the key factors driving the growth of the market.
Furthermore, the increasing preference for minimally invasive (MI) procedures among patients is also providing a boost to the market growth. For instance, deep brain stimulation (DBS) is an MI procedure that uses neurostimulation devices to deliver electrical signals to a specific spot in the brain circuits. This aids in treating various degenerative disorders, such as Parkinson's and Alzheimer's disease.
Additionally, technological advancements, including the development of devices that can electronically stimulate the nervous system to restore vision and regain post-paralysis motor movements, are creating a positive outlook for the market. Other factors, including significant growth in the medical industry, increasing healthcare expenditure and extensive research and development (R&D) activities, are projected to drive the market in the upcoming years.
The competitive landscape of the industry has also been examined with some of the key players being Biocontrol Medical, Boston Scientific Corporation, Cyberonics Inc., Medtronic Inc., Neuronetics Inc., Neuropace Inc., Neurosigma Inc., Nevro Corporation, ST. Jude Medical Inc., Synapse Biomedical Inc., etc.
Key Questions Answered
- How has the global neurostimulation devices market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What is the breakup of the market based on the stimulation type?
- What is the breakup of the market based on the device type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the market?
- What is the structure of the global neurostimulation devices market and who are the key players?
- What is the degree of competition in the market?
Key Topics Covered
2 Scope and Methodology
3 Executive Summary
4.2 Key Industry Trends
5 Global Neurostimulation Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Forecast
6 Market Breakup by Stimulation Type
6.1 Internal Stimulation
6.2 External Stimulation
7 Market Breakup by Device Type
7.1 SCS (Spinal Cord Stimulation) Devices
7.2 DBS (Deep Brain Stimulation) Devices
7.3 SNS (Sacral Nerve Stimulation) Devices
7.4 VNS (Vagus Nerve Stimulation) Devices
7.5 GES (Gastric Electrical Stimulation) Devices
7.6 Transcutaneous Electrical Nerve Stimulation Devices
7.7 Transcranial Magnetic Stimulation Devices
8 Market Breakup by Application
8.1 Pain Management
8.3 Essential Tremors
8.4 Urinary and Fecal Incontinence
8.7 Parkinson's Disease
9 Market Breakup by End-User
9.1 Rehabilitation Centers
9.3 Medical Clinics
10 Market Breakup by Region
10.1 North America
10.3 Asia Pacific
10.4 Latin America
10.5 Middle East and Africa
11 SWOT Analysis
12 Value Chain Analysis
12.2 Inbound Logistics
12.4 Outbound Logistics
12.5 Marketing and Sales
12.6 Post Sales Services
13 Porters Five Forces Analysis
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Biocontrol Medical
126.96.36.199 Company Overview
188.8.131.52 Product Portfolio
15.3.2 Boston Scientific Corporation
15.3.3 Cyberonics Inc.
15.3.4 Medtronic Inc.
15.3.5 Neuronetics Inc.
15.3.6 Neuropace Inc.
15.3.7 Neurosigma Inc.
15.3.8 Nevro Corporation
15.3.9 St. Jude Medical Inc.
15.3.10 Synapse Biomedical Inc.
For more information about this report visit https://www.researchandmarkets.com/r/rd6h63